BR0213581A - Uso de um inibidor de recaptação de norepinefrina seletivo - Google Patents
Uso de um inibidor de recaptação de norepinefrina seletivoInfo
- Publication number
- BR0213581A BR0213581A BR0213581-7A BR0213581A BR0213581A BR 0213581 A BR0213581 A BR 0213581A BR 0213581 A BR0213581 A BR 0213581A BR 0213581 A BR0213581 A BR 0213581A
- Authority
- BR
- Brazil
- Prior art keywords
- norepinephrine reuptake
- reuptake inhibitor
- selective norepinephrine
- selective
- cognitive impairment
- Prior art date
Links
- 239000002767 noradrenalin uptake inhibitor Substances 0.000 title abstract 2
- 208000028698 Cognitive impairment Diseases 0.000 abstract 2
- 208000010877 cognitive disease Diseases 0.000 abstract 2
- 206010012218 Delirium Diseases 0.000 abstract 1
- 206010012289 Dementia Diseases 0.000 abstract 1
- VHGCDTVCOLNTBX-QGZVFWFLSA-N atomoxetine Chemical class O([C@H](CCNC)C=1C=CC=CC=1)C1=CC=CC=C1C VHGCDTVCOLNTBX-QGZVFWFLSA-N 0.000 abstract 1
- 229960002430 atomoxetine Drugs 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- VXDBNICIXSFBIP-UHFFFAOYSA-N n-phenoxy-n-propylaniline Chemical class C=1C=CC=CC=1N(CCC)OC1=CC=CC=C1 VXDBNICIXSFBIP-UHFFFAOYSA-N 0.000 abstract 1
- CBQGYUDMJHNJBX-RTBURBONSA-N reboxetine Chemical class CCOC1=CC=CC=C1O[C@H](C=1C=CC=CC=1)[C@@H]1OCCNC1 CBQGYUDMJHNJBX-RTBURBONSA-N 0.000 abstract 1
- 229960003770 reboxetine Drugs 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33917401P | 2001-12-11 | 2001-12-11 | |
| PCT/US2002/036132 WO2003049724A1 (en) | 2001-12-11 | 2002-11-27 | Use of norepinephrine reuptake inhibitors for the treatment of cognitive failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0213581A true BR0213581A (pt) | 2004-08-24 |
Family
ID=23327833
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0213581-7A BR0213581A (pt) | 2001-12-11 | 2002-11-27 | Uso de um inibidor de recaptação de norepinefrina seletivo |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US20050009925A1 (https=) |
| EP (1) | EP1458368B1 (https=) |
| JP (1) | JP2005517647A (https=) |
| KR (1) | KR20040066895A (https=) |
| CN (1) | CN1713900A (https=) |
| AU (1) | AU2002352625A1 (https=) |
| BR (1) | BR0213581A (https=) |
| CA (1) | CA2467802A1 (https=) |
| CO (1) | CO5590907A2 (https=) |
| CZ (1) | CZ2004709A3 (https=) |
| DE (1) | DE60223718T2 (https=) |
| EA (1) | EA200400793A1 (https=) |
| EC (1) | ECSP045145A (https=) |
| ES (1) | ES2295435T3 (https=) |
| HR (1) | HRPK20040528B3 (https=) |
| HU (1) | HUP0402619A3 (https=) |
| IL (1) | IL161989A0 (https=) |
| MX (1) | MXPA04005716A (https=) |
| MY (1) | MY136367A (https=) |
| NO (1) | NO20042904L (https=) |
| NZ (1) | NZ532065A (https=) |
| PL (1) | PL369311A1 (https=) |
| SK (1) | SK2442004A3 (https=) |
| TW (1) | TW200300672A (https=) |
| WO (1) | WO2003049724A1 (https=) |
| ZA (1) | ZA200404274B (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1530476A1 (en) * | 2002-08-14 | 2005-05-18 | Pharmacia & Upjohn Company LLC | Use of reboxetine for the treatment of hot flashes |
| EP1708717B1 (en) * | 2003-07-28 | 2011-10-05 | Leslie Joe Dunaway | Atomoxetine for treatment of allergic rhinitis and asthma |
| EP1660064A2 (en) * | 2003-08-27 | 2006-05-31 | Eli Lilly And Company | Treatment of learning disabilities and motor skills disorder with norepinephrine reuptake inhibitors |
| EP1729754B1 (en) * | 2003-12-12 | 2008-07-02 | Eli Lilly And Company | Selective norepinephrine reuptake inhibitors for the treatment of hot flashes |
| BRPI0510453A (pt) * | 2004-04-30 | 2007-10-30 | Warner Lambert Co | composto substituìdos com morfolina para o tratamento de distúrbios do sistema nervoso central |
| US7439399B2 (en) * | 2004-06-28 | 2008-10-21 | Teva Pharmaceutical Fine Chemicals | Processes for the preparation of atomoxetine hydrochloride |
| US8580776B2 (en) * | 2007-07-10 | 2013-11-12 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating neurodegenerating diseases |
| US20100069389A1 (en) * | 2008-09-06 | 2010-03-18 | Bionevia Pharmaceuticals, Inc. | Novel forms of reboxetine |
| US20100317730A1 (en) * | 2009-06-12 | 2010-12-16 | Shaya Elias K | Treatment for menopausal and perimenopausal vasomotor symptons |
| WO2011014475A2 (en) * | 2009-07-31 | 2011-02-03 | National Taiwan University | Treating negative symptoms of schizophrenia associated with defective neuregulin 1 |
| JP6126531B2 (ja) * | 2011-10-03 | 2017-05-10 | 国立研究開発法人国立長寿医療研究センター | タウ凝集阻害剤 |
| US20140206667A1 (en) | 2012-11-14 | 2014-07-24 | Michela Gallagher | Methods and compositions for treating schizophrenia |
| US9907799B2 (en) | 2013-04-02 | 2018-03-06 | The Doshisha | Tau aggregation inhibitor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4314081A (en) * | 1974-01-10 | 1982-02-02 | Eli Lilly And Company | Arloxyphenylpropylamines |
| US5281624A (en) * | 1991-09-27 | 1994-01-25 | Eli Lilly And Company | N-alkyl-3-phenyl-3-(2-substituted phenoxy) propylamines and pharmaceutical use thereof |
| US5658590A (en) * | 1995-01-11 | 1997-08-19 | Eli Lilly And Company | Treatment of attention-deficit/hyperactivity disorder |
| US6465458B1 (en) * | 1999-07-01 | 2002-10-15 | Pharmacia & Upjohn Company | Method of treating or preventing chronic pain with a highly selective norepinephrine reuptake inhibitor |
| AP2002002481A0 (en) * | 1999-10-13 | 2002-06-30 | Pfizer Prod Inc | Biaryl ether derivatives useful as monoamine reuptake inhibitors. |
| AU2002243451A1 (en) * | 2001-01-02 | 2002-07-16 | Sention, Inc. | Use of catecholamine reuptake inhibitors to enhance memory |
| JP2004517112A (ja) * | 2001-01-02 | 2004-06-10 | ファルマシア・アンド・アップジョン・カンパニー | 新規薬物コンビネーション |
-
2002
- 2002-11-27 BR BR0213581-7A patent/BR0213581A/pt not_active IP Right Cessation
- 2002-11-27 WO PCT/US2002/036132 patent/WO2003049724A1/en not_active Ceased
- 2002-11-27 IL IL16198902A patent/IL161989A0/xx unknown
- 2002-11-27 EA EA200400793A patent/EA200400793A1/ru unknown
- 2002-11-27 AU AU2002352625A patent/AU2002352625A1/en not_active Abandoned
- 2002-11-27 NZ NZ532065A patent/NZ532065A/en unknown
- 2002-11-27 CZ CZ2004709A patent/CZ2004709A3/cs unknown
- 2002-11-27 ES ES02789574T patent/ES2295435T3/es not_active Expired - Lifetime
- 2002-11-27 JP JP2003550773A patent/JP2005517647A/ja active Pending
- 2002-11-27 CA CA002467802A patent/CA2467802A1/en not_active Abandoned
- 2002-11-27 KR KR10-2004-7009039A patent/KR20040066895A/ko not_active Withdrawn
- 2002-11-27 SK SK244-2004A patent/SK2442004A3/sk not_active Application Discontinuation
- 2002-11-27 DE DE60223718T patent/DE60223718T2/de not_active Expired - Fee Related
- 2002-11-27 CN CNA028247264A patent/CN1713900A/zh active Pending
- 2002-11-27 HU HU0402619A patent/HUP0402619A3/hu unknown
- 2002-11-27 HR HR20040528A patent/HRPK20040528B3/xx not_active IP Right Cessation
- 2002-11-27 EP EP02789574A patent/EP1458368B1/en not_active Expired - Lifetime
- 2002-11-27 US US10/496,765 patent/US20050009925A1/en not_active Abandoned
- 2002-11-27 MX MXPA04005716A patent/MXPA04005716A/es not_active Application Discontinuation
- 2002-11-27 PL PL02369311A patent/PL369311A1/xx unknown
- 2002-12-05 TW TW091135296A patent/TW200300672A/zh unknown
- 2002-12-05 MY MYPI20024591A patent/MY136367A/en unknown
-
2004
- 2004-05-31 ZA ZA200404274A patent/ZA200404274B/en unknown
- 2004-06-09 CO CO04054292A patent/CO5590907A2/es not_active Application Discontinuation
- 2004-06-09 EC EC2004005145A patent/ECSP045145A/es unknown
- 2004-07-09 NO NO20042904A patent/NO20042904L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2467802A1 (en) | 2003-06-19 |
| DE60223718D1 (de) | 2008-01-03 |
| US20050009925A1 (en) | 2005-01-13 |
| ECSP045145A (es) | 2004-07-23 |
| KR20040066895A (ko) | 2004-07-27 |
| DE60223718T2 (de) | 2008-10-30 |
| ZA200404274B (en) | 2005-09-13 |
| HRPK20040528B3 (en) | 2006-03-31 |
| CZ2004709A3 (cs) | 2004-10-13 |
| AU2002352625A1 (en) | 2003-06-23 |
| EP1458368A1 (en) | 2004-09-22 |
| HUP0402619A2 (hu) | 2005-03-29 |
| TW200300672A (en) | 2003-06-16 |
| JP2005517647A (ja) | 2005-06-16 |
| SK2442004A3 (en) | 2004-12-01 |
| MXPA04005716A (es) | 2004-12-06 |
| CO5590907A2 (es) | 2005-12-30 |
| WO2003049724A1 (en) | 2003-06-19 |
| NO20042904L (no) | 2004-09-07 |
| EP1458368B1 (en) | 2007-11-21 |
| ES2295435T3 (es) | 2008-04-16 |
| EA200400793A1 (ru) | 2004-10-28 |
| NZ532065A (en) | 2007-03-30 |
| HRP20040528A2 (en) | 2004-10-31 |
| IL161989A0 (en) | 2005-11-20 |
| CN1713900A (zh) | 2005-12-28 |
| PL369311A1 (en) | 2005-04-18 |
| HUP0402619A3 (en) | 2008-04-28 |
| MY136367A (en) | 2008-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR032086A1 (es) | Combinaciones de farmacos | |
| BR0213581A (pt) | Uso de um inibidor de recaptação de norepinefrina seletivo | |
| ECSP17046065A (es) | Formas cristalinas de (-)-(1r,2r)-3-(3-dimetilamino-1-etil-2-metilpropil)-fenolhidrocloruro (solicitud divisional) | |
| BR0113669A (pt) | Inibidores da desacetilase | |
| NO20005224L (no) | BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse | |
| UY28348A1 (es) | Compuestos novedosos | |
| BR0317715A (pt) | Composições e processos de uso de collajolie | |
| BR0215405A (pt) | Composições e processos de uso de collajolie | |
| AR026163A1 (es) | Utilizacion de retigabina para el tratamiento de dolores neuropaticos | |
| BRPI0412684A (pt) | compostos ppar-ativos | |
| NO20053088L (no) | Farmasoytisk preparat inneholdende en beta-3-adrenoseptoragonist og en serotonin og/eller norepinefrin-gjenopptakelsesinhibitor og anvendelse av nevnte preparat for behandling av blaeredysfunksjon. | |
| BRPI0212733B8 (pt) | composição farmacêutica compreendendo composto inibidor da recaptação de serotonina, e, uso do mesmo | |
| PT1259512E (pt) | Compostos de pteridin para o tratamento da psoriase | |
| BR0312785A (pt) | Tratamento de desordens relacionadas a tnf(alfa) | |
| PT1328269E (pt) | Associacao de um antagonista do receptor cb1 e de sibutramina composicoes farmaceuticas que os contem e sua utilizacao para o tratamento da obesidade | |
| BRPI0312649A2 (pt) | compostos, composições farmacêuticas contendo os mesmos, e processos de uso para os mesmos. | |
| AR036288A1 (es) | Composicion de limpieza mejorada | |
| BR0114903A (pt) | 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação | |
| BRPI0515721A (pt) | uso de um inibidor de src cinase e um inibidor de bcr-abl, composição farmacêutica e combinação | |
| AR047553A1 (es) | La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina | |
| EE200300547A (et) | Laiaspektrilised 2-aminobensoksasoolsulfoonamiidid kui HIV proteaasi inhibiitorid, nende kasutamine, farmatseutiline kompositsioon ja meetod retroviiruse replikatsiooni inhibeerimiseks | |
| MXPA03008674A (es) | Procedimiento para la hidrogenacion de compuestos de carbonilo. | |
| BR0115301A (pt) | Uso de um inibidor seletivo da recaptação de norepinefrina | |
| BRPI0416157A (pt) | composição farmacêutica contendo um agonista de adrenoceptor beta-3 e um antagonista alfa e/ou um inibidor de 5-alfa redutase | |
| UY27461A1 (es) | Formas pseudopolimorficas de cardevilol. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A E 7A ANUIDADES |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2060 DE 29/06/2010. |